DYADIC INTERNATIONAL INC Basic Shares Outstanding (Weighted Average)
DYADIC INTERNATIONAL INC (DYAI) reported Basic Shares Outstanding (Weighted Average) of 28.83 million shares for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2024-05-14
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic for the quarter ending 2024-03-31 was 28.83M shares, a 0.23% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic for the quarter ending 2023-12-31 was 28.81M shares, a 0.91% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic for the quarter ending 2023-09-30 was 28.81M shares, a 1.48% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic for the quarter ending 2023-06-30 was 28.81M shares, a 1.93% increase year-over-year.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic for fiscal 2023 was 28.80M shares, a 1.53% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC weighted average number of shares outstanding, basic for fiscal 2022 was 28.36M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2024-03-31 | 28.83M shares 10-Q · filed 2024-05-14 | 28.82M shares derived: average of 2 quarters · filed 2024-05-14 | 28.82M shares derived: average of 3 quarters · filed 2024-05-14 | 28.82M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | 28.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 28.81M shares derived: average of 2 quarters · filed 2024-03-28 | 28.81M shares derived: average of 3 quarters · filed 2024-03-28 | 28.80M shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 28.81M shares 10-Q · filed 2023-11-08 | 28.81M shares derived: average of 2 quarters · filed 2023-11-08 | 28.79M shares 10-Q · filed 2023-11-08 | 28.73M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2023-06-30 | 28.81M shares 10-Q · filed 2023-08-09 | 28.79M shares 10-Q · filed 2023-08-09 | 28.71M shares derived: average of 3 quarters · filed 2024-05-14 | 28.63M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2023-03-31 | 28.76M shares 10-Q · filed 2024-05-14 | 28.66M shares derived: average of 2 quarters · filed 2024-05-14 | 28.57M shares derived: average of 3 quarters · filed 2024-05-14 | 28.49M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 28.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 28.47M shares derived: average of 2 quarters · filed 2024-03-28 | 28.40M shares derived: average of 3 quarters · filed 2024-03-28 | 28.36M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 28.39M shares 10-Q · filed 2023-11-08 | 28.33M shares derived: average of 2 quarters · filed 2023-11-08 | 28.30M shares 10-Q · filed 2023-11-08 | |
| 2022-06-30 | 28.26M shares 10-Q · filed 2023-08-09 | 28.26M shares 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |